FDA inspection
CutisPharma, Inc.: FDA inspection ending Dec 20, 2017
FDA inspection 1038444 · No Action Indicated (NAI) · Wilmington, MA
Key facts
| Inspection ID | 1038444 |
|---|---|
| Firm | CutisPharma, Inc. |
| FEI number | 3003395329 |
| Address | 841 Woburn St |
| City | Wilmington |
| State | MA |
| ZIP | 01887-3414 |
| Fiscal year | 2018 |
| Inspection end date | Dec 20, 2017 |
| Classification | No Action Indicated (NAI) |
| Project area | New Drug Evaluation |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- Yes Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data